Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

BACKGROUND: Several clinical studies have established the efficacy, safety, and tolerability of long-acting risperidone administered once every 2 weeks in patients with schizophrenia or schizoaffective disorder. This report evaluates preliminary efficacy, safety, tolerability, and pharmacokinetic da...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gharabawi, Georges M, Gearhart, Natalie C, Lasser, Robert A, Mahmoud, Ramy A, Zhu, Young, Mannaert, Erik, Naessens, Ineke, Bossie, Cynthia A, Kujawa, Mary, Simpson, George M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2007
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1803785/
https://ncbi.nlm.nih.gov/pubmed/17261186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-859X-6-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados